Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 02/28 01:29:16 pm
103.725 EUR   -0.55%
02/23DJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
02/23DJBAYER : CEO Still Upbeat on Deal -- WSJ
02/22DJBAYER : Details Financing Plan for Monsanto Deal
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
02/22/2017 02/23/2017 02/24/2017 02/27/2017 02/28/2017 Date
107.9(c) 105.1(c) 104.25(c) 104.3(c) 103.8 Last
3 379 746 2 625 845 2 509 386 1 399 370 542 016 Volume
-0.92% -2.59% -0.81% +0.05% -0.48% Change
More quotes
Financials (€)
Sales 2017 49 087 M
EBIT 2017 9 510 M
Net income 2017 5 481 M
Debt 2017 10 233 M
Yield 2017 2,73%
Sales 2018 51 120 M
EBIT 2018 10 129 M
Net income 2018 6 070 M
Debt 2018 11 483 M
Yield 2018 2,97%
P/E ratio 2017 16,35
P/E ratio 2018 14,73
EV / Sales2017 1,97x
EV / Sales2018 1,91x
Capitalization 86 251 M
More Financials
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
03/15 | 05:00amShareholder meeting
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
02/23DJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
02/23DJBAYER : CEO Still Upbeat on Deal -- WSJ
02/22DJBAYER : Details Financing Plan for Monsanto Deal
02/22 EU regulators set to clear Dow, DuPont deal - sources
02/22 Covestro parent Bayer non-committal on any sale to industry peer
02/22DJBAYER : CEO Confident Monsanto Purchase Will Be Approved by End of Year -- Updat..
02/22 BAYER : Financial News Conference -- Address by Johannes Dietsch -- Member of th..
02/22 BAYER : Financial News Conference -- Address by Werner Baumann -- Chairman of th..
02/22DJBAYER : Upbeat Bayer Posts Lower Profit With Monsanto in its Sights--Update
02/22 FISCAL 2016 : -- Another record year for Bayer - good progress with the acquisit..
More news
Sector news : Pharmaceuticals - NEC
01:21p VALEANT PHARMACEUTICALS INTL : Pharma's revenue falls for third straight quarter
08:35aDJASTRAZENECA : FDA OKs Once-Daily Qtern for Type-2 Diabetes
02/27DJJOHNSON & JOHNSON : Prescription Unit List Prices Rose 8.5% Last Year
02/27 FTSE ends higher on some positive earnings, insurers slip
02/27DJSANOFI : Lonza to Invest CHF290 Million in New Plant in Switzerland
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
2016Good timing to anticipate the return of volatility
2016A technical turn-around configuration
More Strategies
Latest Tweets
04:30aWhy Bayer recruited 1,800 people named Smith from Fort Smith, Ark., for its n..
8
02/27Why Bayer recruited 1,800 people named Smith from Fort Smith, Ark., for its n..
5
02/27Why Bayer recruited 1,800 people named Smith from Fort Smith, Ark., for its n..
7
02/27Bayer Looks Beyond Xarelto And Eylea  
02/27Bayer AG given €119.00 PT by Commerzbank Ag. buy rating.  
More tweets
Qtime:193
News from SeekingAlpha
02/27 RESVERLOGIX : The Science Is Getting 'BETter' For RVX208
02/27 Bayer Looks Beyond Xarelto And Eylea
02/26 MONSANTO : Acquisition By Bayer A Done Deal? Not So Fast.
02/24 The Risks Keep Rising For Roche's Hemophilia Hope
02/24 2 Pairs Trades You Can Take To The Bank
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 111 €
Spread / Average Target 6,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG5.16%91 402
JOHNSON & JOHNSON6.53%332 993
ROCHE HOLDING LTD.5.42%209 283
PFIZER INC.5.48%204 030
NOVARTIS AG4.72%203 039
MERCK & CO., INC.12.38%181 558
More Results